The National Institute of Mental Health (NIMH) convened a meeting in September 2005 to
review tobacco use and dependence and smoking cessation among those with mental …

Opioid tolerance, dependence, and addiction are all manifestations of brain changes resulting
from chronic opioid abuse. The opioid abuser’s struggle for recovery is in great part a …

This article reviews cigarette smoking in patients with psychiatric disorders (PD) and substance
use disorders (SUD). Rates of smoking are approximately 23% in the US population but …

Background Cigarette smoking rates in schizophrenia are higher than in the general
population. Objectives To determine whether cigarette smoking modifies cognitive deficits in …

OBJECTIVE: Schizophrenic patients have high rates of cigarette smoking. The authors
compared the outcomes of two group psychotherapy programs for smoking cessation in patients …

Background: Schizophrenic patients have high rates of cigarette smoking compared with
the general population. We compared sustained-release (SR) bupropion with placebo for …

Nicotine use is a major public health problem that increases medical morbidity and mortality.
Nicotine's action and the pathobiology of schizophrenic disorders have common …

Background Substantial variability exists in therapeutic response and adverse effects with
pharmacotherapies for tobacco dependence. Biomarkers to optimise treatment choice for …

There is growing interest in non-invasive brain stimulation (NIBS) as a novel treatment
option for substance-use disorders (SUDs). Recent momentum stems from a foundation of …

Cigarette smoking rates in the American population are approximately 23%, whereas rates
of smoking in clinical and population studies of individuals with neuropsychiatric disorders …